XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net profit (loss) $ 457,378 $ (444,489)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 30,419 55,669
Deferred tax assets 9,222
Change in operating assets and liabilities:    
Accounts receivable (533,795) 133,684
Inventories 22,196 93,711
Deposits, prepayments and other receivables (5,723,476) 343,954
Contract liabilities (125,163) 600,235
Accounts payables 6,956,385 27,743
Accrued liabilities and other payables (923,394) (1,131,318)
Advances (from) to related parties (1,665,910) 4,462
Right of use assets 65,743 59,072
Operating lease liabilities (67,359) (67,747)
Net cash used in operating activities (1,506,976) (315,802)
Cash flows from investing activity:    
Purchase of plant, and equipment (4,884)
Net cash used in investing activities (4,884)
Cash flows from financing activity:    
Proceeds from issuance of shares 1,600,002
Net cash used in financing activities 1,600,002
Effect on exchange rate change on cash and cash equivalents (101,712) (14,203)
NET CHANGE IN CASH AND CASH EQUIVALENTS (13,570) (330,005)
CASH AND CASH EQUIVALENT AT BEGINNING OF YEAR 6,988,007 670,547
CASH AND CASH EQUIVALENT AT END OF YEAR 6,974,437 340,542
Supplemental disclosure of cash flow information:    
Cash paid for interest 63
Cash paid for income tax
Reconciliation to amounts on condensed unaudited consolidated balance sheets:    
Cash and cash equivalents 6,924,437 286,642
Restricted cash 50,000 53,900
Total cash, cash equivalents and restricted cash $ 6,974,437 $ 340,542